Researchers from the University Hospital Düsseldorf have uncovered an important link between circulating extracellular vesicles (EVs) and patient outcomes following a liver procedure known as transjugular intrahepatic portosystemic shunt, or TIPS. This procedure helps reduce dangerously high blood pressure in the portal vein, a common and life-threatening complication of cirrhosis.
In their analysis of 141 patients who underwent TIPS, the team measured the size and concentration of EVs, tiny particles released by cells that carry signals throughout the body and play key roles in immune regulation and inflammation. They found that patients with larger EVs tended to have more severe liver disease and poorer transplant-free survival rates one year after the procedure. Interestingly, EV size, but not their total concentration, was independently linked to clinical outcomes even after accounting for other established liver function scores.
The findings suggest that EV characteristics could serve as valuable biomarkers for identifying patients at higher risk following TIPS placement. With further research, measuring extracellular vesicle size may become a useful tool for guiding treatment decisions and improving prognosis in patients with advanced liver disease.
Exosome RNA Exosome RNA Research & Industry News

